ONCASPAR (PEGASPARGASE)
NCASPAR (pegaspargase) is indicated as a component of a multi-agent chemotherapeutic regimen for the first–line treatment of patients with acute lymphoblastic leukemia (ALL) and for the treatment of patients with ALL and hypersensitivity to native forms of L-asparaginase.
ONCASPAR (PEGASPARGASE)
Industry:
Medical Device
Founded:
1986-01-01
Website Url:
http://www.oncaspar.com
Status:
Active
Contact:
844-229-7575
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Tag Manager Amazon Amazon Virginia Region DigiCert SSL Pound Sterling Typekit Japanese Yen
Official Site Inspections
http://www.oncaspar.com Semrush global rank: 6.58 M Semrush visits lastest month: 954
- Host name: 20.232.9.129
- IP address: 20.232.9.129
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ONCASPAR (pegaspargase)"
ONCASPAR (pegaspargase) - Crunchbase Company …
ONCASPAR (pegaspargase) is indicated as a component of a multi-agent chemotherapeutic regimen.See details»
Oncaspar · Servier Canada Inc · 235 Boul. Armand-Frappier - Parc ...
Oncaspar is a drug product manufactured by SERVIER CANADA INC, according to the data provided by Health Canada. The update date is June 4, 2019.See details»
Regulatory Decision Summary for Oncaspar - Drug and Health …
Review decision The Regulatory Decision Summary explains Health Canada’s decision for the product seeking market authorization. The Regulatory Decision Summary includes the …See details»
Details for: ONCASPAR - Drug and Health Products Portal
Information on drug and health products authorized by Health Canada.See details»
[Product Monograph Template - Schedule D]
DESCRIPTION ONCASPAR (pegaspargase) is a pegylated form of L-asparaginase, an enzyme that breaks down L-asparagine. L-asparaginase hydrolyses the non-essential amino acid, L …See details»
oncaspar, A World Intellectual Property Organization Trademark of ...
The oncaspar trademark was assigned an Application Number #1764609 by the World Intellectual Property Organization (WIPO). Trademark Application Number is a Unique ID to identify the …See details»
HCP Support for ONCASPAR® (pegaspargase)
Learn how to get financial support for ONCASPAR® (pegaspargase), your patients could be eligible to receive assistance through the ONCASPAR® (pegaspargase) Patient Assistance Program (PAP).See details»
Oncaspar Global Market Report 2025 - Oncaspar Market Scope …
Oncaspar Market 2025: Projected to hit USD by 2029 at 9.7% CAGR. Access in-depth analysis on trends, market dynamics, and competitive landscape for data-driven decisions.See details»
Oncaspar: Uses, Dosage, Side Effects, Food Interaction & FAQ
Jan 7, 2025 Learn about Oncaspar uses, dosage, side effects, food interactions, and more. Get all the details about Oncaspar from MedicinesFAQ.See details»
Oncaspar | Health Canada - DPD | PharmaCompass.com
List of Approved drugs containing Oncaspar listed with Health Canada in the Drug Product Database (DPD)See details»
Oncaspar | Digital Content | PharmaCompass.com
5FDF Dossiers Reset all filters About Digital Content Create Content with PharmaCompass, ask us DATA COMPILATION #PharmaFlowSee details»
PATIENT MEDICATION INFORMATION - Servier Canada
ONCASPAR contains pegaspargase, which is an enzyme that breaks down L-asparagine, an important building block of proteins without which cells cannot survive. Normal cells can make …See details»
Frequently Asked Questions About Oncaspar® (Pegaspargase)
Jun 1, 2018 Oncaspar has been formulated to remain active in the body for a longer period of time than asparaginase. Oncaspar produces its anti-cancer effects in the same manner as …See details»
Oncaspar | Drug Information, Uses, Side Effects, Chemistry ...
Know about technical details of Oncaspar like: chemical name, chemistry structure, formulation, uses, toxicity, action, side effects and more at Pharmacompass.com.See details»
Oncaspar - Side Effects, Uses, Dosage, Overdose, Pregnancy
Nov 8, 2013 Oncaspar - Get up-to-date information on Oncaspar side effects, uses, dosage, overdose, pregnancy, alcohol and more. Learn more about OncasparSee details»
Oncaspar Patient Assistance Program - prescriberpoint.com
The Oncaspar Patient Assistance Program offers invaluable support to eligible patients by providing the drug Oncaspar free of charge. This program is designed to assist uninsured or …See details»
Oncaspar (Pegaspargase) for Leukemia | MyLeukemiaTeam
Overview Oncaspar is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat acute lymphoblastic leukemia (ALL). Oncaspar is often used as a …See details»
Oncaspar - Healio
This medication is usually used to treat acute lymphocytic leukemia (ALL), especially in patients who are allergic to L-asparaginase. It works by starving tumor cells of a certain amino acid ...See details»
PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION …
PART I: HEALTH PROFESSIONAL INFORMATION ONCASPAR (pegaspargase) is a pegylated form of L-asparaginase, an enzyme that breaks down L-asparagine. L-asparaginase …See details»
Oncaspar - patient leaflet, side effects, dosage
Oncaspar is used to treat acute lymphoblastic leukaemia (ALL) in children from birth to 18 years and in adults. ALL is a white blood cell cancer type in which certain immature white cells …See details»